Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing

Clinical trial NCT06943586 · RECRUITING

Trial details

NCT number: NCT06943586
Sponsor: University of Alabama at Birmingham
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Stroke Transient Ischemic Attack (TIA)

Start date: 2025-04-09
Primary completion: 2028-04-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.